Are Roselabs Finance Ltd latest results good or bad?

2 hours ago
share
Share Via
Roselabs Finance Ltd's latest results are concerning, with zero revenue and a net loss of ₹0.16 crores in Q4 FY26, indicating significant operational challenges and financial distress, including a negative book value and a debt-to-equity ratio suggesting insolvency risks.
The latest financial results for Roselabs Finance Ltd for Q4 FY26 indicate significant operational challenges. The company reported net sales of ₹0.00 crores, marking a complete absence of revenue generation, which is a stark contrast to the ₹1.21 crores recorded in the previous quarter. This trend of zero sales has persisted across multiple quarters, highlighting the company's struggle to maintain its core business activities as a non-banking financial company (NBFC).
In terms of profitability, Roselabs Finance Ltd incurred a net loss of ₹0.16 crores in Q4 FY26, which is a notable decline from the loss of ₹0.04 crores in Q3 FY26. This deterioration was exacerbated by an unusual tax charge, leading to a negative tax rate that raises concerns about potential legacy tax liabilities. The operating profit before interest, depreciation, and tax (PBDIT) also worsened slightly, reflecting ongoing operational inefficiencies. The company's balance sheet reveals a negative book value of ₹-4.73 per share, indicating that shareholder equity has been completely eroded. This situation is compounded by a debt-to-equity ratio of -1.02, suggesting that liabilities exceed assets, which typically raises insolvency concerns. Current assets are minimal at ₹0.12 crores, overshadowed by current liabilities, further emphasizing the financial distress. Overall, the financial data illustrates a company that has effectively ceased operations, with no meaningful revenue generation and persistent losses. The situation has prompted an adjustment in the company's evaluation, reflecting the severity of its financial challenges and lack of operational viability.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News